fda approval tirzepatide GROUNDBREAKING UPDATE! has approved TIRZEPATIDE, a pioneering obesity treatment activating GIP & GLP-1 receptors, for weight loss! Previously, has been FDA approved for type 2 diabetes as Mounjaro, and although Lilly's new drug Mounjaro (tirzepatide

How does Bio-B 100 work in the body

None of these mechanisms interfere with GLP-1, GIP, or glucagon receptor signaling

doi:10.2337/diabetes.42.11.1678

While this effect appears to be related to the magnitude and rapidity of glucose lowering rather than a direct effect of the medication itself, patients with a history of diabetic retinopathy should undergo careful ophthalmologic evaluation before and during treatment, and the potential risks should be weighed against the expected benefits of improved glycemic control

In AD, along with amyloid and tau phosphorylation, there is an associated increase in inflammation/glial activation, a decrease in synaptic function, an increase in astrocyte activation, and a state of insulin resistance

The skin on my arms, legs, and neck had taken on a slightly poultry-esque consistency